Correlation Between Durect and Syros Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Durect and Syros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Durect and Syros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Durect and Syros Pharmaceuticals, you can compare the effects of market volatilities on Durect and Syros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Durect with a short position of Syros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Durect and Syros Pharmaceuticals.

Diversification Opportunities for Durect and Syros Pharmaceuticals

0.76

Correlation Coefficient

Durect  Syros Pharmaceuticals

Poor diversification

The 3 months correlation between Durect and Syros is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Durect and Syros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syros Pharmaceuticals and Durect is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Durect are associated (or correlated) with Syros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syros Pharmaceuticals has no effect on the direction of Durect i.e., Durect and Syros Pharmaceuticals go up and down completely randomly.

Pair Corralation between Durect and Syros Pharmaceuticals

Given the investment horizon of 90 days Durect is expected to under-perform the Syros Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Durect is 3.1 times less risky than Syros Pharmaceuticals. The stock trades about -0.21 of its potential returns per unit of risk. The Syros Pharmaceuticals is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest  157.00  in Syros Pharmaceuticals on September 12, 2024 and sell it today you would lose (132.51) from holding Syros Pharmaceuticals or give up 84.4% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Durect  vs.  Syros Pharmaceuticals

Durect

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Durect has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Syros Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Syros Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Durect and Syros Pharmaceuticals

The main advantage of trading using opposite Durect and Syros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Durect position performs unexpectedly, Syros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syros Pharmaceuticals will offset losses from the drop in Syros Pharmaceuticals' long position.

The idea behind Durect and Syros Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.